PONOI CAPITAL, LP

CIK 1707230 · last filed 2023-01-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

13

Lifetime Open-Market Net

$92.51M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted 10%+ Owner 11,583,875 $1.54 $17.84M $79.61M 8 2023-01-12
RAPT Therapeutics, Inc. (RAPT) Delisted 10%+ Owner 175,251 $58.01 $10.17M -$91.40M 2 2021-09-16
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted 10%+ Owner 4,159,186 $33.99 $141.37M $104.30M 3 2021-02-19

Recent Filings · Page 2 of 2

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-10-07 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Buy (P) +12,705,876 $108.00M EDGAR
2019-07-31 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +280,560 $3.84M EDGAR
2019-07-15 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +318,840 $4.43M EDGAR
Showing 1113 of 13
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.